These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17393569)

  • 1. "Computer analysis of liver texture with correlation to biopsy".
    Krnic A
    Ultraschall Med; 2007 Feb; 28(1):85; author reply 85-6. PubMed ID: 17393569
    [No Abstract]   [Full Text] [Related]  

  • 2. Computerised analysis of liver texture with correlation to needle biopsy.
    Gaitini D; Lederman M; Baruch Y; Ghersin E; Veitsman E; Kerner H; Shalem B; Yaniv G; Sarfaty C; Azhari H
    Ultraschall Med; 2005 Jun; 26(3):197-202. PubMed ID: 15948055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility study of ultrasonic fatty liver biopsy: texture vs. attenuation and backscatter.
    Gaitini D; Baruch Y; Ghersin E; Veitsman E; Kerner H; Shalem B; Yaniv G; Sarfaty C; Azhari H
    Ultrasound Med Biol; 2004 Oct; 30(10):1321-7. PubMed ID: 15582231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis.
    Borges VF; Diniz AL; Cotrim HP; Rocha HL; Andrade NB
    J Clin Ultrasound; 2013 Jan; 41(1):18-25. PubMed ID: 22997020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoechoic lesions in the 'bright liver': a reliable indicator of fatty change. A prospective study.
    Caturelli E; Squillante MM; Andriulli A; Cedrone A; Cellerino C; Pompili M; Manoja ER; Rapaccini GL
    J Gastroenterol Hepatol; 1992; 7(5):469-72. PubMed ID: 1391727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple liver lesions of unusual benign etiology mimicking metastatic disease.
    Pais TP; Fernandes S; Fraga J
    Gastroenterology; 2014 Aug; 147(2):e10-1. PubMed ID: 24973686
    [No Abstract]   [Full Text] [Related]  

  • 7. Multifocal nodular fatty infiltration of the liver mimicking metastatic liver tumors: diagnosis using the liver-specific late phase of Levovist-enhanced sonography.
    Tamai H; Shingaki N; Oka M; Shiraki T; Inoue I; Magari H; Fujishiro M; Iguchi M; Yanaoka K; Arii K; Shimizu Y; Ichinose M
    J Ultrasound Med; 2006 Mar; 25(3):403-6. PubMed ID: 16495505
    [No Abstract]   [Full Text] [Related]  

  • 8. Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload.
    Mendler MH; Bouillet P; Le Sidaner A; Lavoine E; Labrousse F; Sautereau D; Pillegand B
    J Hepatol; 1998 May; 28(5):785-94. PubMed ID: 9625313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of fatty liver disease: is biopsy necessary?
    Joy D; Thava VR; Scott BB
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):539-43. PubMed ID: 12702913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive tests for liver fibrosis: encouraging or discouraging results?
    Burroughs AK; Cholongitas E
    J Hepatol; 2007 May; 46(5):751-5. PubMed ID: 17383047
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypoechoic lesions in fatty liver. Quantitative study by histomorphometry.
    Caturelli E; Costarelli L; Giordano M; Fusilli S; Squillante MM; Pompili M; Rapaccini GL; Livraghi T
    Gastroenterology; 1991 Jun; 100(6):1678-82. PubMed ID: 2019373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive assessment of liver steatosis in deceased donors: A pilot study.
    Cesaretti M; Poté N; Cauchy F; Dondero F; Dokmak S; Sepulveda A; Schneck AS; Francoz C; Durand F; Paradis V; Soubrane O
    Liver Transpl; 2018 Apr; 24(4):551-556. PubMed ID: 29272077
    [No Abstract]   [Full Text] [Related]  

  • 13. [A clinical and pathological study of nonalcoholic fatty liver disease].
    Zheng RD; Lu LG; Meng JR; Huang JD; Rao RC; Xu CR; Zeng MD
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):449-52. PubMed ID: 16792871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal spared area in fatty liver mimicking a tumor.
    Fujikawa K; Shiraki K; Ito T; Takase K; Nakano T
    Hepatogastroenterology; 2002; 49(47):1253-4. PubMed ID: 12239916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenon-133 retention in hepatic steatosis-correlation with liver biopsy in 45 patients: concise communication.
    Ahmad M; Perrillo RP; Sunwoo YC; Donati RM
    J Nucl Med; 1979 May; 20(5):397-401. PubMed ID: 541696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitfalls in ultrasonographic diagnosis with fatty infiltration of the liver.
    Hutton L; Rankin RN
    J Can Assoc Radiol; 1983 Dec; 34(4):303-5. PubMed ID: 6668295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal spared areas in fatty liver caused by regional decreased portal flow.
    Arai K; Matsui O; Takashima T; Ida M; Nishida Y
    AJR Am J Roentgenol; 1988 Aug; 151(2):300-2. PubMed ID: 3293374
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of the liver changes by B-ultrasound and histopathology in severe pregnancy induced hypertension].
    Yang Z; Ye R; Miao L
    Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):453-5. PubMed ID: 10806739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intense FDG activity in focal hepatic steatosis.
    Le Y; Chen Y; Huang Z; Cai L; Zhang L
    Clin Nucl Med; 2014 Jul; 39(7):669-72. PubMed ID: 24873789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HIV and the liver].
    Cadranel JF; Wendum D; Pialoux G
    Gastroenterol Clin Biol; 2001 Jan; 25(1):93-6. PubMed ID: 11275622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.